Tuscan Cats: Good News for Owners & Felines

by Archynetys News Desk

“`html

Remdesivir Use Approved for Feline Infectious Peritonitis in Italy

Italian cats gain access to Remdesivir treatment for FIP, thanks to a new circular anticipating EU regulations.


Cat owners in Italy are celebrating a new directive that allows the use of Remdesivir to treat Feline Infectious Peritonitis (FIP). The announcement has been welcomed by animal lovers and veterinarians alike, who have long sought additional tools to combat this challenging disease.

The policy shift comes as the Undersecretary of Health, Marcello Gemmato, signed an explanatory circular permitting the use of veklury, a drug based on Remdesivir, for treating FIP. This decision anticipates a European Regulation slated to take effect on August 8, 2026.

Vittorio Fantozzi, group leader of Fratelli d’Italia in the Tuscany Regional Council, stated: “Good news for all 3.6 million Tuscan cats and for those who love them. From Friday it is possible to use the RemDesivir for felines. An act of common sense by the Fratelli d’Italia.”

The circular clarifies that the drug’s use for felines will not impact its availability for human COVID-19 treatment. Veterinary doctors will issue prescriptions under their direct obligation, and the costs will not be borne by the national health system.

Implications for cat Owners

The approval offers a new option for Italian cat owners facing an FIP diagnosis. Previously, the disease was often a death sentence, but Remdesivir has shown promise in treating FIP in clinical trials.

“A great news for all animal lovers arrives from Rome…in the unfortunate hypothesis that Fip contracted.”

The decision reflects a broader concern for animal welfare, with Fantozzi noting, “Together with all the other social problems, the centre -right and brothers of Italy also take charge of this issue that concerns about 3.6 million cats in Tuscany and about 14 million in Italy, according to the most recent surveys.”

Political Dimensions

The move has been hailed as a victory for animal rights advocates and a testament to the Meloni government‘s commitment to animal welfare. “For all of us who love animals a great result, for Fratelli d’Italia and the coalition that supports the Meloni government another flagship, as we keep faith with a promise made to the animalist associations and veterinary doctors who had repeatedly urged this provision,” said a representative.

fantozzi added, “Together with the recent Law Brambilla, the Meloni government makes the strong national animal rightsman makes an exceptional qualitative leap.”

Frequently Asked Questions About FIP and Remdesivir

What is Feline Infectious Peritonitis (FIP)?
FIP is a fatal disease in cats caused by a mutated form of the feline coronavirus. It has wet and dry forms, both leading to severe illness.
How does Remdesivir treat FIP?
Remdesivir is an antiviral medication that has shown promise in inhibiting the replication of the FIP virus, potentially slowing or stopping the disease’s progression.
Will using Remdesivir for cats affect its availability for human COVID-19 treatment?
No, the Italian circular specifies that using Remdesivir for felines will not impact its availability for human COVID-19 treatment.

Related Posts

Leave a Comment